Notably in breast cancer pathogenesis, Kaplan-Meier survival analysis reveals clinically significant correlations: patients with high CKS2 expression exhibit reduced overall survival, shorter recurrence-free survival, and diminished distant metastasis-free survival compared to low-expression cohorts13. This evidence concerns the gene CKS2 and breast carcinoma.